Techno Medical Public Company Limited

SET:TM Stock Report

Market Cap: ฿326.5m

Techno Medical Past Earnings Performance

Past criteria checks 0/6

Techno Medical's earnings have been declining at an average annual rate of -53.4%, while the Healthcare industry saw earnings growing at 12.4% annually. Revenues have been growing at an average rate of 1.4% per year.

Key information

-53.4%

Earnings growth rate

-53.4%

EPS growth rate

Healthcare Industry Growth23.6%
Revenue growth rate1.4%
Return on equity-7.5%
Net Margin-3.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Techno Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SET:TM Revenue, expenses and earnings (THB Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24726-222350
30 Jun 24711-232380
31 Mar 24711-152310
31 Dec 23697-42250
30 Sep 2368532220
30 Jun 2367492150
31 Mar 23656122150
31 Dec 22645132120
30 Sep 22628152000
30 Jun 22689412000
31 Mar 22683361980
31 Dec 21675302020
30 Sep 21675342030
30 Jun 21617221930
31 Mar 21615291890
31 Dec 20632411830
30 Sep 20628411830
30 Jun 20640451920
31 Mar 20654521930
31 Dec 19690611960
30 Sep 19717602030
30 Jun 19702631990
31 Mar 19698612050
31 Dec 18645482070
30 Sep 18652572010
30 Jun 18639382110
31 Mar 18630372100
31 Dec 17629352100
30 Sep 17593202120
30 Jun 17579312000
31 Mar 17567271960
31 Dec 16557271910
30 Sep 16570361880
30 Jun 16560251890
31 Mar 16537281810
31 Dec 15512291740
31 Dec 14404351450
31 Dec 13362201540

Quality Earnings: TM is currently unprofitable.

Growing Profit Margin: TM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: TM is unprofitable, and losses have increased over the past 5 years at a rate of 53.4% per year.

Accelerating Growth: Unable to compare TM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TM is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (8.5%).


Return on Equity

High ROE: TM has a negative Return on Equity (-7.55%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 12:23
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Techno Medical Public Company Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hathaichanoke MoonwongPhillip Securities (Thailand) PCL